“Clinical trials of new therapies for [Alzheimer’s disease] typically allow participants to continue receiving [cholinesterase inhibitors] and memantine during the trial if the dose remains stable,” Richard E. Kennedy, MD, PhD.
Arthur Monsetin is a fictional character, but the story of his fading memory and declining comprehension is one that will ring true to the millions of Americans suffering from dementia, and the family members who struggle along with them.
This project addresses the growing unmet need for alternative approaches to mitigating cognitive decline by introducing a robot companion that will interact and motivate patients in order to reinforce therapeutic behavior
Curing some of the most vexing diseases first requires navigating the world's most complex structure -- the human brain. So, USC scientists have created the most detailed atlas yet of the brain's memory bank.